NORGES BANK - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$9,690,476
-11.6%
145,067
+14.0%
0.00%
-33.3%
Q3 2022$10,958,961
+0.9%
127,267
+4.5%
0.00%0.0%
Q2 2022$10,864,587
-23.4%
121,773
-3.4%
0.00%0.0%
Q1 2022$14,182,852
-25.0%
126,081
+3.0%
0.00%
-25.0%
Q4 2021$18,915,000
+41.7%
122,456
+27.8%
0.00%
+33.3%
Q3 2021$13,345,000
+86.6%
95,790
+75.7%
0.00%
+50.0%
Q2 2021$7,152,000
-59.2%
54,513
-52.6%
0.00%
-50.0%
Q1 2021$17,546,000
+31.0%
115,091
-14.6%
0.00%
+33.3%
Q4 2020$13,396,000
+3.7%
134,704
-0.6%
0.00%0.0%
Q3 2020$12,922,000
-36.8%
135,563
-25.8%
0.00%
-50.0%
Q2 2020$20,444,000
+32.3%
182,782
-14.0%
0.01%0.0%
Q1 2020$15,452,000
-34.7%
212,481
-6.3%
0.01%
-14.3%
Q4 2019$23,646,000
+0.8%
226,729
-3.8%
0.01%0.0%
Q3 2019$23,465,000
-12.8%
235,7370.0%0.01%
-12.5%
Q2 2019$26,910,000
-9.2%
235,7370.0%0.01%
-20.0%
Q1 2019$29,635,000
-7.4%
235,7370.0%0.01%
-16.7%
Q4 2018$31,990,000
-47.7%
235,737
+5.8%
0.01%
-40.0%
Q3 2018$61,135,000
+41.6%
222,721
+6.8%
0.02%
+33.3%
Q2 2018$43,184,000
+33.4%
208,449
+6.3%
0.02%
+25.0%
Q1 2018$32,374,000
+34.2%
196,017
+11.3%
0.01%
+33.3%
Q4 2017$24,116,000
+12.4%
176,117
+11.8%
0.01%
+12.5%
Q3 2017$21,452,000
+12.1%
157,5650.0%0.01%0.0%
Q2 2017$19,128,000
+17.3%
157,565
+2.3%
0.01%
+14.3%
Q1 2017$16,301,000
-16.4%
154,014
-19.7%
0.01%
-22.2%
Q4 2016$19,500,000
+4.2%
191,9070.0%0.01%0.0%
Q3 2016$18,707,000
-12.2%
191,907
+7.5%
0.01%
-10.0%
Q2 2016$21,297,000
+29.0%
178,565
+15.8%
0.01%
+25.0%
Q1 2016$16,510,000
-1.2%
154,1650.0%0.01%0.0%
Q4 2015$16,715,000
+26.6%
154,1650.0%0.01%
+14.3%
Q3 2015$13,204,000
+109.7%
154,165
+147.0%
0.01%
+133.3%
Q2 2015$6,298,000
+111.9%
62,417
+61.9%
0.00%
+200.0%
Q1 2015$2,972,000
+44.9%
38,5430.0%0.00%0.0%
Q4 2014$2,051,00038,5430.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders